placeholder image
M. A. Nauck All authors
About
Publications While At 开云体育
selected publications
Journal Article
  • Liraglutide and cardiovascular outcomes in type 2 diabetes. 
    New England Journal of Medicine. 2016
  • LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations. 
    Diabetes, Obesity & Metabolism. 2015
  • LEADER 3--lipase and amylase activity in subjects with type 2 diabetes: baseline data from over 9000 subjects in the LEADER Trial. 
    Pancreas. 2014
  • Design of the liraglutide effect and action in diabetes: evaluation of cardiovascular outcome results (LEADER) trial. 
    American Heart Journal. 2013
  • Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial. 
    Lancet (London, England). 2010
    • Contact
    full name
  • M. A. Nauck
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
    Collaboration